However, SARS-CoV-2-specific CD4+ T cells, SARS-CoV-2-specific CD8+ T cells, and neutralizing antibodies were detected in the blood of most COVID-19 cases in this study, indicating the experimental approach was informative and the conclusions are reasonable. The gene discussed is CD4; the disease is COVID-19.